The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dupilumab Drug Market Research Report 2025
Synopsis
The global market for Dupilumab Drug was valued at US$ 18570 million in the year 2024 and is projected to reach a revised size of US$ 36530 million by 2031, growing at a CAGR of 10.3% during the forecast period.
Dupilumab is a fully human monoclonal antibody used to treat a range of chronic inflammatory conditions driven by type 2 inflammation, such as moderate-to-severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, and prurigo nodularis. It works by inhibiting the signaling of interleukin-4 (IL-4) and interleukin-13 (IL-13), which are key cytokines involved in allergic and inflammatory responses. Developed by Sanofi and Regeneron, dupilumab is administered via subcutaneous injection and has shown significant clinical efficacy in reducing disease symptoms and improving quality of life in patients.
North American market for Dupilumab Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dupilumab Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Dupilumab Drug include Sanofi, Swixx Biopharma, ABACUS MEDICINE, Amicus Llc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dupilumab Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dupilumab Drug.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Dupilumab Drug competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Dupilumab Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dupilumab Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dupilumab Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi
Swixx Biopharma
ABACUS MEDICINE
Amicus Llc
Segment by Type
200mg (1.14mL)/Vial
300mg (2.0 mL)/Vial
Segment by Application
Hospitals
Retail Pharmacy
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dupilumab Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dupilumab Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Dupilumab Drug was valued at US$ 18570 million in the year 2024 and is projected to reach a revised size of US$ 36530 million by 2031, growing at a CAGR of 10.3% during the forecast period.
Dupilumab is a fully human monoclonal antibody used to treat a range of chronic inflammatory conditions driven by type 2 inflammation, such as moderate-to-severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, and prurigo nodularis. It works by inhibiting the signaling of interleukin-4 (IL-4) and interleukin-13 (IL-13), which are key cytokines involved in allergic and inflammatory responses. Developed by Sanofi and Regeneron, dupilumab is administered via subcutaneous injection and has shown significant clinical efficacy in reducing disease symptoms and improving quality of life in patients.
North American market for Dupilumab Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dupilumab Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Dupilumab Drug include Sanofi, Swixx Biopharma, ABACUS MEDICINE, Amicus Llc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dupilumab Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dupilumab Drug.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Dupilumab Drug competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Dupilumab Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dupilumab Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dupilumab Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi
Swixx Biopharma
ABACUS MEDICINE
Amicus Llc
Segment by Type
200mg (1.14mL)/Vial
300mg (2.0 mL)/Vial
Segment by Application
Hospitals
Retail Pharmacy
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dupilumab Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dupilumab Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Dupilumab Drug Market Overview
1.1 Product Definition
1.2 Dupilumab Drug by Type
1.2.1 Global Dupilumab Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 200mg (1.14mL)/Vial
1.2.3 300mg (2.0 mL)/Vial
1.3 Dupilumab Drug by Application
1.3.1 Global Dupilumab Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Dupilumab Drug Market Size Estimates and Forecasts
1.4.1 Global Dupilumab Drug Revenue 2020-2031
1.4.2 Global Dupilumab Drug Sales 2020-2031
1.4.3 Global Dupilumab Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dupilumab Drug Market Competition by Manufacturers
2.1 Global Dupilumab Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dupilumab Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dupilumab Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dupilumab Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dupilumab Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dupilumab Drug, Product Type & Application
2.7 Global Key Manufacturers of Dupilumab Drug, Date of Enter into This Industry
2.8 Global Dupilumab Drug Market Competitive Situation and Trends
2.8.1 Global Dupilumab Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dupilumab Drug Players Market Share by Revenue
2.8.3 Global Dupilumab Drug Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dupilumab Drug Market Scenario by Region
3.1 Global Dupilumab Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dupilumab Drug Sales by Region: 2020-2031
3.2.1 Global Dupilumab Drug Sales by Region: 2020-2025
3.2.2 Global Dupilumab Drug Sales by Region: 2026-2031
3.3 Global Dupilumab Drug Revenue by Region: 2020-2031
3.3.1 Global Dupilumab Drug Revenue by Region: 2020-2025
3.3.2 Global Dupilumab Drug Revenue by Region: 2026-2031
3.4 North America Dupilumab Drug Market Facts & Figures by Country
3.4.1 North America Dupilumab Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dupilumab Drug Sales by Country (2020-2031)
3.4.3 North America Dupilumab Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dupilumab Drug Market Facts & Figures by Country
3.5.1 Europe Dupilumab Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dupilumab Drug Sales by Country (2020-2031)
3.5.3 Europe Dupilumab Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dupilumab Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Dupilumab Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dupilumab Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Dupilumab Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dupilumab Drug Market Facts & Figures by Country
3.7.1 Latin America Dupilumab Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dupilumab Drug Sales by Country (2020-2031)
3.7.3 Latin America Dupilumab Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dupilumab Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Dupilumab Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dupilumab Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dupilumab Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dupilumab Drug Sales by Type (2020-2031)
4.1.1 Global Dupilumab Drug Sales by Type (2020-2025)
4.1.2 Global Dupilumab Drug Sales by Type (2026-2031)
4.1.3 Global Dupilumab Drug Sales Market Share by Type (2020-2031)
4.2 Global Dupilumab Drug Revenue by Type (2020-2031)
4.2.1 Global Dupilumab Drug Revenue by Type (2020-2025)
4.2.2 Global Dupilumab Drug Revenue by Type (2026-2031)
4.2.3 Global Dupilumab Drug Revenue Market Share by Type (2020-2031)
4.3 Global Dupilumab Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dupilumab Drug Sales by Application (2020-2031)
5.1.1 Global Dupilumab Drug Sales by Application (2020-2025)
5.1.2 Global Dupilumab Drug Sales by Application (2026-2031)
5.1.3 Global Dupilumab Drug Sales Market Share by Application (2020-2031)
5.2 Global Dupilumab Drug Revenue by Application (2020-2031)
5.2.1 Global Dupilumab Drug Revenue by Application (2020-2025)
5.2.2 Global Dupilumab Drug Revenue by Application (2026-2031)
5.2.3 Global Dupilumab Drug Revenue Market Share by Application (2020-2031)
5.3 Global Dupilumab Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Dupilumab Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Dupilumab Drug Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Swixx Biopharma
6.2.1 Swixx Biopharma Company Information
6.2.2 Swixx Biopharma Description and Business Overview
6.2.3 Swixx Biopharma Dupilumab Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Swixx Biopharma Dupilumab Drug Product Portfolio
6.2.5 Swixx Biopharma Recent Developments/Updates
6.3 ABACUS MEDICINE
6.3.1 ABACUS MEDICINE Company Information
6.3.2 ABACUS MEDICINE Description and Business Overview
6.3.3 ABACUS MEDICINE Dupilumab Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ABACUS MEDICINE Dupilumab Drug Product Portfolio
6.3.5 ABACUS MEDICINE Recent Developments/Updates
6.4 Amicus Llc
6.4.1 Amicus Llc Company Information
6.4.2 Amicus Llc Description and Business Overview
6.4.3 Amicus Llc Dupilumab Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Amicus Llc Dupilumab Drug Product Portfolio
6.4.5 Amicus Llc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dupilumab Drug Industry Chain Analysis
7.2 Dupilumab Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dupilumab Drug Production Mode & Process Analysis
7.4 Dupilumab Drug Sales and Marketing
7.4.1 Dupilumab Drug Sales Channels
7.4.2 Dupilumab Drug Distributors
7.5 Dupilumab Drug Customer Analysis
8 Dupilumab Drug Market Dynamics
8.1 Dupilumab Drug Industry Trends
8.2 Dupilumab Drug Market Drivers
8.3 Dupilumab Drug Market Challenges
8.4 Dupilumab Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Dupilumab Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Dupilumab Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Dupilumab Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Dupilumab Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Dupilumab Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Dupilumab Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Dupilumab Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Dupilumab Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Dupilumab Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Dupilumab Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dupilumab Drug, Product Type & Application
Table 12. Global Key Manufacturers of Dupilumab Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dupilumab Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dupilumab Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dupilumab Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Dupilumab Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Dupilumab Drug Sales Market Share by Region (2020-2025)
Table 19. Global Dupilumab Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Dupilumab Drug Sales Market Share by Region (2026-2031)
Table 21. Global Dupilumab Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Dupilumab Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Dupilumab Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Dupilumab Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Dupilumab Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Dupilumab Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Dupilumab Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Dupilumab Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Dupilumab Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Dupilumab Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Dupilumab Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Dupilumab Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Dupilumab Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Dupilumab Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Dupilumab Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Dupilumab Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Dupilumab Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Dupilumab Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Dupilumab Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Dupilumab Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Dupilumab Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Dupilumab Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Dupilumab Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Dupilumab Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Dupilumab Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Dupilumab Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Dupilumab Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Dupilumab Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Dupilumab Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Dupilumab Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Dupilumab Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Dupilumab Drug Sales Market Share by Type (2020-2025)
Table 53. Global Dupilumab Drug Sales Market Share by Type (2026-2031)
Table 54. Global Dupilumab Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Dupilumab Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Dupilumab Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Dupilumab Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Dupilumab Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Dupilumab Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Dupilumab Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Dupilumab Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Dupilumab Drug Sales Market Share by Application (2020-2025)
Table 63. Global Dupilumab Drug Sales Market Share by Application (2026-2031)
Table 64. Global Dupilumab Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Dupilumab Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Dupilumab Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Dupilumab Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Dupilumab Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Dupilumab Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Dupilumab Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Sanofi Dupilumab Drug Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Swixx Biopharma Company Information
Table 76. Swixx Biopharma Description and Business Overview
Table 77. Swixx Biopharma Dupilumab Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Swixx Biopharma Dupilumab Drug Product
Table 79. Swixx Biopharma Recent Developments/Updates
Table 80. ABACUS MEDICINE Company Information
Table 81. ABACUS MEDICINE Description and Business Overview
Table 82. ABACUS MEDICINE Dupilumab Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. ABACUS MEDICINE Dupilumab Drug Product
Table 84. ABACUS MEDICINE Recent Developments/Updates
Table 85. Amicus Llc Company Information
Table 86. Amicus Llc Description and Business Overview
Table 87. Amicus Llc Dupilumab Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Amicus Llc Dupilumab Drug Product
Table 89. Amicus Llc Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Dupilumab Drug Distributors List
Table 93. Dupilumab Drug Customers List
Table 94. Dupilumab Drug Market Trends
Table 95. Dupilumab Drug Market Drivers
Table 96. Dupilumab Drug Market Challenges
Table 97. Dupilumab Drug Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Dupilumab Drug
Figure 2. Global Dupilumab Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Dupilumab Drug Market Share by Type: 2024 & 2031
Figure 4. 200mg (1.14mL)/Vial Product Picture
Figure 5. 300mg (2.0 mL)/Vial Product Picture
Figure 6. Global Dupilumab Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Dupilumab Drug Market Share by Application: 2024 & 2031
Figure 8. Hospitals
Figure 9. Retail Pharmacy
Figure 10. Others
Figure 11. Global Dupilumab Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Dupilumab Drug Market Size (2020-2031) & (US$ Million)
Figure 13. Global Dupilumab Drug Sales (2020-2031) & (K Units)
Figure 14. Global Dupilumab Drug Average Price (US$/Unit) & (2020-2031)
Figure 15. Dupilumab Drug Report Years Considered
Figure 16. Dupilumab Drug Sales Share by Manufacturers in 2024
Figure 17. Global Dupilumab Drug Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Dupilumab Drug Players: Market Share by Revenue in Dupilumab Drug in 2024
Figure 19. Dupilumab Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Dupilumab Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Dupilumab Drug Sales Market Share by Country (2020-2031)
Figure 22. North America Dupilumab Drug Revenue Market Share by Country (2020-2031)
Figure 23. United States Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Dupilumab Drug Sales Market Share by Country (2020-2031)
Figure 26. Europe Dupilumab Drug Revenue Market Share by Country (2020-2031)
Figure 27. Germany Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Dupilumab Drug Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Dupilumab Drug Revenue Market Share by Region (2020-2031)
Figure 34. China Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Dupilumab Drug Sales Market Share by Country (2020-2031)
Figure 42. Latin America Dupilumab Drug Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Dupilumab Drug Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Dupilumab Drug Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Dupilumab Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Dupilumab Drug by Type (2020-2031)
Figure 53. Global Revenue Market Share of Dupilumab Drug by Type (2020-2031)
Figure 54. Global Dupilumab Drug Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Dupilumab Drug by Application (2020-2031)
Figure 56. Global Revenue Market Share of Dupilumab Drug by Application (2020-2031)
Figure 57. Global Dupilumab Drug Price (US$/Unit) by Application (2020-2031)
Figure 58. Dupilumab Drug Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
